Search Results - "Diaz, Dayssy A."

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review by Yaney, Alexander, Stevens, Andrew, Monk, Paul, Martin, Douglas, Diaz, Dayssy A, Wang, Shang-Jui

“…Globally, prostate cancer is one of the most common malignancies affecting men. With the advent of advanced molecular imaging, an increasing number of men are…”
Get full text

Promoting Women and Historically Excluded Minorities in Medicine as Essential Leaders of Research by Iheagwara, Uzoma K., Patel, Shilpen, Diaz, Dayssy A., Yom, Sue S., Goodman, Karyn A., Barry, Parul N.

“…Women and historically excluded minorities are underrepresented in clinical research. At the ASTRO 2021 annual meeting, the authors reviewed several strategies…”
Get full text

Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer by Fabian, Denise, Ayan, Ahmet, DiCostanzo, Dominic, Barney, Christian L, Aljabban, Jihad, Diaz, Dayssy A, Miller, Eric D, Wuthrick, Evan, Williams, Terence M, Bazan, Jose G

“…To test the hypothesis that increasing radiation dose to the thoracic marrow (TM) contributes to the development of hematologic toxicities (HT) in esophageal…”
Get full text

Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma by Shannon, Alexander H, Manne, Ashish, Diaz Pardo, Dayssy A, Pawlik, Timothy M

“…Hepatocellular Carcinoma (HCC) is one of the most common cancers and a leading cause of cancer related death worldwide. Until recently, systemic therapy for…”
Get full text

The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy by Udayakumar, Thirupandiyur, PhD, Shareef, Mohammed M., PhD, Diaz, Dayssy A., MD, Ahmed, Mansoor M., PhD, Pollack, Alan, MD, PhD

“…Both the p53- and E2F1-signaling pathways are defective in almost all types of tumors, suggesting very important roles for their signaling networks in…”
Get full text

Smoking Cessation at a Safety-Net Hospital: A Radiation Oncology Resident-Led Quality Improvement Initiative by Ramey, Stephen J., Silver, Benjamin, Diaz, Dayssy A., Munjal, Akul, Mehta, Shahil, Rich, Benjamin, Yechieli, Raphael, Takita, Cristiane

“…Continued smoking among patients with cancer has been associated with increased toxicities, resistance to treatment, and recurrence. This resident-led quality…”
Get full text

Long-term Clinical Outcomes of Yttrium-90 Transarterial Radioembolization for Hepatocellular Carcinoma: A 5-Year Institutional Experience by Makary, Mina S., Bozer, Jordan, Miller, Eric D., Diaz, Dayssy A., Rikabi, Ali

“…To examine the clinical outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) for primary hepatocellular carcinoma (HCC) through the evaluation…”
Get full text

Disparities in outcomes and access to therapy options in hepatocellular carcinoma by Beltrán Ponce, Sara, Gokun, Yevgeniya, Douglass, Francisca, Dawson, Laura, Miller, Eric, Thomas, Jr, Charles R, Pitter, Kenneth, Conteh, Lanla, Diaz, Dayssy A

“…Hepatocellular carcinoma (HCC) disproportionately impacts racial and ethnic minorities and patients with lower socioeconomic status. These social determinants…”
Get full text

S126 Association Between Neighborhood Opportunity and Guideline Concordant Hepatocellular Carcinoma Surveillance by Bouquet, Erin, Jiang, Joanna, Gnyawali, Bipul, Diaz, Dayssy A., Conteh, Lanla F., Elsaid, Mohamed I., Sobotka, Lindsay A.

Get full text

Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma by Ruff, Samantha M., Diaz, Dayssy A., Pitter, Kenneth L., Hartwell, Bridget C., Pawlik, Timothy M.

Get full text

Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis by Jiang, Joanna, Bouquet, Erin, Kweon, Yesung, Elsaid, Mohamed I., Diaz, Dayssy A., Conteh, Lanla, Sobotka, Lindsay A.

“…•The Ohio opportunity Index is a reliable, multidimensional tool used to quantify the effect of neighborhood opportunity on completion of hepatocellular…”
Get full text

Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists by Ritter, Alex R, Prasad, Rahul N, Jhawar, Sachin R, Bazan, Jose G, Gokun, Yevgeniya, Vudatala, Sundari, Diaz, Dayssy A

“…For many malignancies, hypofractionated radiotherapy (HFRT) is an accepted standard associated with decreased treatment time and costs. United States provider…”
Get full text

Prospective dual-surrogate validation study of periodic imaging during treatment for accurately monitoring intrafraction motion of prostate cancer patients by Cetnar, Ashley, Ayan, Ahmet S., Graeper, Gavin, Weldon, Michael, Woods, Kyle, Klamer, Brett, Pan, Xueliang, Martin, Douglas D., Diaz, Dayssy A., Gupta, Nilendu

“…•Algorithm accuracy for fiducial marker identification is comparable to Calypso.•When within the 1 cm tolerance status, the difference in vector magnitude of…”
Get full text

Social determinants of health, workforce diversity, and financial toxicity: A review of disparities in cancer care by Beltrán Ponce, Sara E., Thomas, Charles R., Diaz, Dayssy A.

Get full text

Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists by Odei, Bismarck C., Pan, Xueliang, Bello-Pardo, Erika, Mitchell, Darrion, Thomas, Charles R., Diaz, Dayssy A.

“…Patient satisfaction scores (PSS) have been adopted in health care reimbursement and faculty promotion metrics. Oncology patients face a challenging prognosis,…”
Get full text

Treatment Patterns and Outcomes for Patients with Ampullary Carcinoma Who Do Not Undergo Surgery by Facer, Benjin D, Cloyd, Jordan M, Manne, Ashish, Pitter, Kenneth L, Diaz, Dayssy A, Bazan, Jose G, Miller, Eric D

“…Surgical resection is the standard of care for ampullary adenocarcinoma (AC). Many patients are ineligible due to comorbidities/advanced disease. Evidence for…”
Get full text

Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United States by Prasad, Rahul N., Gokun, Yevgeniya, Ritter, Alex R., Jhawar, Sachin R., Vudatala, Sundari, Wang, Shang-Jui, Martin, Douglas, Diaz, Dayssy A.

“…Despite advantages such as abbreviated treatment course, brachytherapy (BT) utilization rates for prostate cancer (PC) in the United States (US) are declining…”
Get full text

Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: A SEER analysis by Wolfson, Aaron H, Reis, Isildinha M, Portelance, Lorraine, Diaz, Dayssy A, Zhao, Wei, Gibb, Randall K

“…Abstract Purpose This study accessed the Surveillance, Epidemiology and End Results (SEER) database to determine if tumor size is an independent predictor of…”
Get full text

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline by Alcorn, Sara, Cortés, Ángel Artal, Bradfield, Lisa, Brennan, Margaret, Dennis, Kristopher, Diaz, Dayssy A., Doung, Yee-Cheen, Elmore, Shekinah, Hertan, Lauren, Johnstone, Candice, Jones, Joshua, Larrier, Nicole, Lo, Simon S., Nguyen, Quynh-Nhu, Tseng, Yolanda D., Yerramilli, Divya, Zaky, Sandra, Balboni, Tracy

“…This guideline provides evidence-based recommendations for palliative external beam radiation therapy (RT) in symptomatic bone metastases. The ASTRO convened a…”
Get full text

Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation by Diaz, Dayssy A., Hurley, Judith, Reis, Isildinha, Takita, Cristiane, Zhao, Wei, Wright, Jean

“…Low rates of locoregional recurrence (LRR) in patients with clinical stage IIB breast cancer (cT2N1 or cT3N0) who undergo neoadjuvant therapy (NAT) and…”
Get full text